Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.

J Immunother Cancer · 2020 · PMC7373331 · PMID 32690771

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In all cases a p value of 0.05 and below was considered significant (*), p<0.01(**), p<0.001 (***) and p<0.0001 (****) as highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.